Post Reply
221-240 of 1294
Sian.. Look like a bye bye stock
Watch when it starts to turn the corner to go back Up!
Looking good to accumulate...They have posted very decent profits.
got strenght later today?
100 lots makan at 0.5
Going down...
today all luckstre movments...think weekend ...all already go happy hour...see next week...to see this back to 57-60 range
pcxiao2008 ( Date: 14-Aug-2020 14:25) Posted:
|
" Hyphens has continued to grow its skin health portfolio. It received a patent in the UK for Ceradan Advanced, a next-generation emollient therapy scientifically formulated for eczema-prone skin conditions. The group will continue to undertake further clinical developments to reinforce the Ceradan brand' s positioning.
Hyphens has also expanded the skin health portfolio to include hair growth products, by acquiring CG 210, a patented topical botanical hair growth-promoting agent.
For the first half of the year, net profit after tax increased 39.8 per cent on the year to S$4.3 million, while revenue was up 10.1 per cent to S$61.6 million.
All three of the group' s business segments contributed to the half-year revenue increase, with proprietary brands leading with a 29.8 per cent growth. The medical hypermart and digital segment also contributed 8.2 per cent more revenue, compared with a year ago.
The company on Thursday reiterated its plans to enhance its service offering to capture the growing opportunities in telemedicine.
" We will speed up our investment in e-commerce for our consumer healthcare brands and step up digital engagement with medical professionals," it said.
Aside from going digital, Hyphens is also actively pursuing prospective partners in its efforts to internationalise to other parts of Asia for its proprietary brands."
to move shortly ....back to green
later should go back to 56/57
Hyphens Q2 profit up 32% on robust sales of skin health products, supplements
AN increase in sales in proprietary brands gave a boost to Hyphens Pharma International' s bottom line for the second quarter ended June 30, the Catalist-listed specialty pharmaceutical and consumer healthcare group said in results released on Thursday night.
Net profit after tax rose 32 per cent to S$2.2 million for the three months, from S$1.6 million a year ago, amid higher revenue and other income, which were partially offset by higher distribution costs and higher administrative expenses.
Earnings per share stood at 0.72 Singapore cent for the quarter, up from 0.52 cent in the corresponding period last year.
Revenue edged up 4.1 per cent year on year to S$30.2 million for the three months, from S$29 million previously.
Next week i think.
look@bright ( Date: 14-Aug-2020 10:52) Posted:
|
Good result laosai? Maybe up too much before result out
Hyphen gone?
i think today is IX to release result.
about the same as previous half
Careful2020 ( Date: 14-Aug-2020 10:48) Posted:
|
How' s the result?
look@bright ( Date: 14-Aug-2020 10:44) Posted:
|
already out yesterday evening
Careful2020 ( Date: 14-Aug-2020 10:43) Posted:
|
When will the result come out? It should be around the corner for the announcement of result these few days..
Wanted to buy but scare😄 so just stay aside and watch...
Jaedoubleu ( Date: 12-Aug-2020 10:05) Posted:
|